BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21371009)

  • 1. Animal models in the drug discovery pipeline for Alzheimer's disease.
    Van Dam D; De Deyn PP
    Br J Pharmacol; 2011 Oct; 164(4):1285-300. PubMed ID: 21371009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of dementia and cognitive dysfunction.
    Neha ; Sodhi RK; Jaggi AS; Singh N
    Life Sci; 2014 Jul; 109(2):73-86. PubMed ID: 25066372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery in dementia: the role of rodent models.
    Van Dam D; De Deyn PP
    Nat Rev Drug Discov; 2006 Nov; 5(11):956-70. PubMed ID: 17080031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non human primate models for Alzheimer's disease-related research and drug discovery.
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2017 Feb; 12(2):187-200. PubMed ID: 27960560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation.
    Anand A; Banik A; Thakur K; Masters CL
    Curr Alzheimer Res; 2012 Nov; 9(9):1010-29. PubMed ID: 22698073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human cognitive neuroscience in drug discovery for the dementias.
    Wesnes KA; Edgar CJ
    Curr Opin Pharmacol; 2014 Feb; 14():62-73. PubMed ID: 24565014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent models for Alzheimer's disease drug discovery.
    Puzzo D; Gulisano W; Palmeri A; Arancio O
    Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease in the zebrafish: where can we take it?
    Caramillo EM; Echevarria DJ
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):179-186. PubMed ID: 28177980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How efficient are rodent models for Alzheimer's disease drug discovery?
    Guo B; Zhou Q
    Expert Opin Drug Discov; 2018 Feb; 13(2):113-115. PubMed ID: 29082769
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of vascular disease in dementia: what does industry want to know?
    Wren PB; Hill D; Lockhart A
    Clin Sci (Lond); 2017 May; 131(9):799-802. PubMed ID: 28424374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta ; Birks J
    Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 13. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs.
    Yamada K; Nabeshima T
    Pharmacol Ther; 2000 Nov; 88(2):93-113. PubMed ID: 11150591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of mice and men: bridging the translational disconnect in CNS drug discovery.
    Geerts H
    CNS Drugs; 2009 Nov; 23(11):915-26. PubMed ID: 19845413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invertebrate models of Alzheimer's disease.
    Link CD
    Genes Brain Behav; 2005 Apr; 4(3):147-56. PubMed ID: 15810903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy.
    Ruehl WW; Bruyette DS; DePaoli A; Cotman CW; Head E; Milgram NW; Cummings BJ
    Prog Brain Res; 1995; 106():217-25. PubMed ID: 8584657
    [No Abstract]   [Full Text] [Related]  

  • 19. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
    Roses AD
    Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.